Professor | Hai-Han Liao | Asia Growth Partners

	Upload Avatar (500 x 500)
Name	Hai-Han Liao
Contact Information	liaohaihan@whu.edu.cn
Language ability	Chinese, English
Province	Hubei

Upload Avatar (500 x 500)

Name

Hai-Han Liao

Contact Information

liaohaihan@whu.edu.cn

Language ability

Chinese, English

Province

Hubei

University/Lab Affiliation and Title	Wuhan University
Faculty	Medical School
Academic Background & Achievements	2007-2012: Bachelor of Clinical Medicine and Technology, Wuhan University 2012-2017: PhD in Internal Medicine, Wuhan University Hosted national natural science foundation projects
Work Experience	2017-2019: Attending Physician, Cardiovascular Department, Renmin Hospital, Wuhan University 2019-present: Associate Chief Physician, Associate Professor, Cardiovascular Department, Renmin Hospital, Wuhan University
Awards	2019: First Prize, Hubei Province Science and Technology Progress Award for 'Structural Remodeling and Prevention of Heart Failure'

University/Lab Affiliation and Title

Wuhan University

Faculty

Medical School

Academic Background & Achievements

2007-2012: Bachelor of Clinical Medicine and Technology, Wuhan University
2012-2017: PhD in Internal Medicine, Wuhan University
Hosted national natural science foundation projects

Work Experience

2017-2019: Attending Physician, Cardiovascular Department, Renmin Hospital, Wuhan University
2019-present: Associate Chief Physician, Associate Professor, Cardiovascular Department, Renmin Hospital, Wuhan University

Awards

2019: First Prize, Hubei Province Science and Technology Progress Award for 'Structural Remodeling and Prevention of Heart Failure'

Areas of Focus	Myocardial remodeling and cardiomyopathy Diagnosis and treatment of cardiovascular diseases
Publications	Activation of AMPKα2 attenuated doxorubicin-induced cardiotoxicity via inhibiting lipid peroxidation associated ferroptosis, Liao HH, Ding W, Zhang N, Zhou ZY, Ling Z, Li WJ, Chen S, Tang QZ, 2023 RIP2 inhibition alleviates lipopolysaccharide-induced septic cardiomyopathy via regulating TAK1 signaling, Lin Z, Liao HH, Zhou ZY, Zhang N, Li WJ, Tang QZ, 2023 Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway, Aiyasiding X, Liao H-H, Feng H, Zhang N, Lin Z, Ding W, Yan H, Zhou Z-Y, Tang Q-Z, 2022 Neutrophil degranulation and myocardial infarction, Zhang N, Aiyasiding X, Li WJ, Liao HH, Tang QZ, 2022 Alternative autophagy: mechanisms and roles in different diseases, Feng H, Wang N, Zhang N, Liao HH, 2022 Knockout of AMPKα2 Blocked the Protection of Sestrin2 Overexpression Against Cardiac Hypertrophy Induced by Pressure Overload, Zhang N, Liao H-H, Feng H, Mou S-Q, Li W-J, Aiyasiding X, Lin Z, Ding W, Zhou Z-Y, Yan H, Chen S, Tang Q-Z, 2021 Cardiomyocyte-Specific RIP2 Overexpression Exacerbated Pathologic Remodeling and Contributed to Spontaneous Cardiac Hypertrophy, Yang JJ, Zhang N, Zhou ZY, Ni J, Feng H, Li WJ, Mou SQ, Wu HM, Deng W, Liao HH, Tang QZ, 2021 Research Progress on the Interaction Between Autophagy and Energy Homeostasis in Cardiac Remodeling, Ding W, Feng H, Li WJ, Liao HH, Tang QZ, 2020 Combination treatment of perifosine and valsartan showed more efficiency in protecting against pressure overload induced mouse heart failure, Li WJ, Liao HH, Feng H, Zhou ZY, Mou SQ, Zhang N, Wu HM, Xia H, Tang QZ, 2020

Areas of Focus

Myocardial remodeling and cardiomyopathy
Diagnosis and treatment of cardiovascular diseases

Publications

Activation of AMPKα2 attenuated doxorubicin-induced cardiotoxicity via inhibiting lipid peroxidation associated ferroptosis, Liao HH, Ding W, Zhang N, Zhou ZY, Ling Z, Li WJ, Chen S, Tang QZ, 2023
RIP2 inhibition alleviates lipopolysaccharide-induced septic cardiomyopathy via regulating TAK1 signaling, Lin Z, Liao HH, Zhou ZY, Zhang N, Li WJ, Tang QZ, 2023
Liquiritin Attenuates Pathological Cardiac Hypertrophy by Activating the PKA/LKB1/AMPK Pathway, Aiyasiding X, Liao H-H, Feng H, Zhang N, Lin Z, Ding W, Yan H, Zhou Z-Y, Tang Q-Z, 2022
Neutrophil degranulation and myocardial infarction, Zhang N, Aiyasiding X, Li WJ, Liao HH, Tang QZ, 2022
Alternative autophagy: mechanisms and roles in different diseases, Feng H, Wang N, Zhang N, Liao HH, 2022
Knockout of AMPKα2 Blocked the Protection of Sestrin2 Overexpression Against Cardiac Hypertrophy Induced by Pressure Overload, Zhang N, Liao H-H, Feng H, Mou S-Q, Li W-J, Aiyasiding X, Lin Z, Ding W, Zhou Z-Y, Yan H, Chen S, Tang Q-Z, 2021
Cardiomyocyte-Specific RIP2 Overexpression Exacerbated Pathologic Remodeling and Contributed to Spontaneous Cardiac Hypertrophy, Yang JJ, Zhang N, Zhou ZY, Ni J, Feng H, Li WJ, Mou SQ, Wu HM, Deng W, Liao HH, Tang QZ, 2021
Research Progress on the Interaction Between Autophagy and Energy Homeostasis in Cardiac Remodeling, Ding W, Feng H, Li WJ, Liao HH, Tang QZ, 2020
Combination treatment of perifosine and valsartan showed more efficiency in protecting against pressure overload induced mouse heart failure, Li WJ, Liao HH, Feng H, Zhou ZY, Mou SQ, Zhang N, Wu HM, Xia H, Tang QZ, 2020

Myocardial Remodeling Cardiomyopathy Cardiovascular Diseases Clinical Prevention Pathogenesis Heart Failure Treatment Strategies Medical Research Heart Health Disease Management

Yangpo Cao - Southern University of Science and Technology

Wang Hairong - Wuhan University

Di Fan - Wuhan University

View All

Personal Information

Academic Information

Research

Contact us

No account yet?

Personal Information

Academic Information

Research

Contact us